Medication Utilisation Program, Quality Improvement and Research Pharmacist-Implementation Strategies and Preliminary Findings
- PMID: 34842809
- PMCID: PMC8628968
- DOI: 10.3390/pharmacy9040182
Medication Utilisation Program, Quality Improvement and Research Pharmacist-Implementation Strategies and Preliminary Findings
Abstract
Judicious use of medicines that considers evidence-based practice, together with cost-effectiveness, is a priority for all health care organisations. We describe an initiative to lead a Medication Utilisation Program, incorporating medication quality improvement and research activities. In August 2020 an advanced pharmacist position was implemented to lead the Program. The purpose was to provide oversight and facilitate initiatives promoting medication optimisation to create sustainable change in practice. A strategic plan was developed with key performance indicators. A governance structure was implemented with relevant reporting mechanisms. Strategic planning and collaboration with medical, nursing and allied health professionals has seen the successful implementation of seven codesigned medication-use evaluations and eight quality improvement projects centred around patient safety, quality and value-based care. Several research studies have been designed with subsequent commencement of pharmacists enrolled in university Research Higher Degree programs. Cost containment initiatives have realised potential savings approximating AUD 250,000. Educational programs included protocol design, ethics approvals and report writing. Key success criteria for a Medication Utilisation Program include dedicated pharmacist resources, structured governance and reporting mechanisms. Alignment of study complexity with staff experience and interdisciplinary collaboration are also critical.
Keywords: clinical pharmacology; medication optimisation; medication quality improvement; medication research; medication utilisation program; medication-use evaluation; pharmacist.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Critical Care Network in the State of Qatar.Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019. Qatar Med J. 2019. PMID: 31763205 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).J Manag Care Pharm. 2011 Jun;17(5):345-54. doi: 10.18553/jmcp.2011.17.5.345. J Manag Care Pharm. 2011. PMID: 21657804 Free PMC article.
-
How Do Pharmacists Practice in Aged Care? A Narrative Review of Models from Australia, England, and the United States of America.Int J Environ Res Public Health. 2021 Dec 3;18(23):12773. doi: 10.3390/ijerph182312773. Int J Environ Res Public Health. 2021. PMID: 34886501 Free PMC article. Review.
-
Pharmacist-led collaborative medication management programs for oral antineoplastic therapies: A systematic literature review.J Am Pharm Assoc (2003). 2021 May-Jun;61(3):e7-e18. doi: 10.1016/j.japh.2020.12.005. Epub 2020 Dec 24. J Am Pharm Assoc (2003). 2021. PMID: 33358357
Cited by
-
Evidence-Based Pharmaceutical Care in Community Pharmacies: A Survey of 595 French Pharmacists.Pharmacy (Basel). 2023 Oct 7;11(5):161. doi: 10.3390/pharmacy11050161. Pharmacy (Basel). 2023. PMID: 37888506 Free PMC article.
References
-
- Australian Government Department of Health What is Quality Use of Medicines? [(accessed on 23 October 2021)];2020 Available online: https://www1.health.gov.au/internet/main/publishing.nsf/Content/nmp-qual....
-
- Institute of Medicine Committee on Quality of Health Care in America . Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy of Sciences; Washington, DC, USA: 2001.
LinkOut - more resources
Full Text Sources